Adapalene
Also known as: 6-[3-(1-Adamantyl)-4-methoxyphenyl]-2-naphthoic acid, CD-271
Description
Adapalene is a third-generation synthetic retinoid that selectively binds to RARβ and RARγ receptors. It offers similar efficacy to tretinoin with improved photostability and tolerability. [Thiboutot 2007]
Mechanism of Action
Selectively binds to nuclear retinoic acid receptors RARβ and RARγ, modulating cellular differentiation and keratinization. Inhibits AP-1 factor and toll-like receptor-mediated inflammatory pathways. More photostable and less irritating than tretinoin. [Shalita 1996]
Indications
- Acne vulgaris [Thiboutot]
- Photoaging (off-label) [Shalita]
- Keratosis pilaris [Thiboutot]
Available Concentrations
Side Effects
- Dryness [Thiboutot]
- Erythema [Thiboutot]
- Scaling [Shalita]
- Burning or stinging
- Photosensitivity (less than tretinoin)
Contraindications
- Pregnancy [Zaenglein]
- Eczematous skin at application site
- Sunburned skin
Pregnancy Category
Found In
Drugs containing Adapalene
Cosmetics containing Adapalene
Related Conditions
References
- Shalita AR, Weiss JS, Chalker DK, et al. "A comparison of the efficacy and safety of adapalene gel 0.1% and tretinoin gel 0.025% in the treatment of acne vulgaris." J Am Acad Dermatol, 1996. doi:10.1016/S0190-9622(96)90753-6
- Thiboutot D, Pariser DM, Egan N, et al. "Adapalene gel 0.3% for the treatment of acne vulgaris: a multicenter, randomized, double-blind, controlled, phase III trial." J Am Acad Dermatol, 2007. doi:10.1016/j.jaad.2006.10.005
- Zaenglein AL, Pathy AL, Schlosser BJ, et al. "Guidelines of care for the management of acne vulgaris." J Am Acad Dermatol, 2016. doi:10.1016/j.jaad.2015.12.037
Limitations
This page provides a general overview of Adapalene in dermatology. It does not cover every possible use, formulation, or interaction. Individual responses to compounds vary — what works for one person may not work for another. Always consult a qualified dermatologist before starting or changing any treatment.